Clinical stage biopharma RAPT Therapeutics filed the paperwork for its IPO on 6/5/19. The company is focused on developing therapies targeting immune drivers of cancer and inflammation. They intend to trade on NASDAQ under the symbol, “RAPT.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,